Esophageal variceal bleeding (EVB) is a potentially fatal complication of cirrhosis. The purpose of the present study was to evaluate the safety and efficacy of a novel technique of balloon-occluded esophageal varices (EVs) obliteration (BEVO) for EVs classified as F2 (medium size, F2-EVs) and F3 (large size, F3-EVs). Between December 2020 and December 2021, a total of 73 consecutive patients with EVs were treated using BEVO. An injection of sclerosant was administered via direct puncture of the varices during balloon occlusion. Immediate postprocedural Doppler endoscopic ultrasonography (EUS) was conducted to evaluate the blood flow in the EVs. Several factors, including the technical success, controlling of acute bleeding, intraoperative bleeding at the injection site, variceal eradication, variceal recurrence, and BEVO-related complications, were assessed. BEVO was successfully performed in all patients. Immediate hemostasis was achieved in 100% (25/25) of patients with active EVB. The incidence of injection site intraoperative bleeding presenting as oozing and spurting bleeding was 76.71% (56/73) and 8.22% (6/73), respectively. Based on Doppler EUS and endoscopic examination, EVs were completely eradicated in 71 out of 73 patients (97.26%) after three sessions. A total of 3 (4.11%) patients were diagnosed with EV recurrence during follow-up after complete EV eradication. Retrosternal chest discomfort (13.70%; 10/73) and abdominal bloating (2.74%; 2/73) were spontaneously relieved after a few days. No serious BEVO-related complications were observed. BEVO is a convenient and effective treatment for obliterating F2 and F3 EVs. Clinical Trial Registration No. ChiCTR2000039974.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/lap.2022.0416 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Endoscopic devices and techniques for the management of gastric varices (with videos).
Gastrointest Endosc
October 2024
Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Background And Aims: Gastric variceal bleeding occurs less commonly than bleeding from esophageal varices (EVs), although it is associated with higher morbidity and mortality. Bleeding from gastroesophageal varices type 1 (GOV1) is treated like EVs. In contrast, other forms of gastric variceal bleeding, including gastroesophageal varices type 2 (GOV2) and isolated gastric varices types 1 (IGV1) and 2 (IGV2), are treated with varying endoscopic approaches.
View Article and Find Full Text PDFTranshepatic Antegrade Gastric Variceal Sclerotherapy: Comparing Outcomes with and without Initial Efferent Vein Embolization.
J Vasc Interv Radiol
January 2025
Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Article Synopsis
- The study aimed to compare the effectiveness of two techniques—percutaneous transhepatic obliteration with initial afferent vein embolization (PTO-A) and initial efferent vein embolization (PTO-E)—for treating gastric varices (GVs).
- 26 patients with type 1 or type 2 gastric varices were treated, with positive outcomes seen in both methods; however, PTO-E demonstrated a significantly higher complete eradication rate (100% vs. 33.3%).
- Patients who underwent PTO-E also experienced a longer median recurrence-free period (75.1 months) compared to those who had PTO-A (8.7 months), although overall survival rates were similar for both groups.
Esophageal Varices as an Independent Predictor of Fatal Outcomes after Balloon-Occluded Retrograde Transvenous Obliteration in Patients with Hepatic Encephalopathy.
Dig Dis
December 2024
Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Article Synopsis
- The study analyzed 107 patients undergoing balloon-occluded retrograde transvenous obliteration (BRTO) due to uncontrollable hepatic encephalopathy (HE) and assessed the impact of esophageal varices (EVs) on outcomes.
- Patients were divided into two groups based on the presence of EVs, and results showed that those with EVs had significantly shorter event-free survival and overall survival compared to those without EVs.
- The findings suggest that having EVs may indicate a higher risk of complications and mortality following the BRTO procedure in HE patients.
Efficacy and safety of inflator-monitored balloon-occluded retrograde transvenous obliteration for gastric varices.
Jpn J Radiol
January 2025
Department of Radiology, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Republic of Korea.
Purpose: To investigate the diagnostic efficacy of inflator-monitored balloon-occluded retrograde transvenous obliteration (ImBRTO) in detecting balloon rupture and to evaluate the efficacy and safety of the ImBRTO in treating gastric varices.
Methods: Between June 2018 and June 2024, 31 consecutive patients (age: 61.7 ± 12.
Evaluation of clinical outcome and predictors of mortality in patients undergoing antegrade transvenous variceal embolization in adjunct to salvage transjugular intrahepatic portosystemic shunt for active uncontrolled gastric variceal bleeding.
Br J Radiol
November 2024
Department of Hepatology, Institute of Liver & Biliary Sciences, New Delhi110070, India.
Objectives: Salvage transjugular intrahepatic portosystemic shunt (TIPS) is indicated in patients with active endoscopically uncontrollable variceal bleeding. TIPS alone is not effective in the management of gastric varices, and balloon occluded transvenous obliteration (BRTO) requires favourable variceal anatomy. Concomitant placement of a TIPS stent with antegrade variceal embolization leads to control of gastric variceal bleeding with no significant increase in portal pressure.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!